Semi-Annual Statement Of Income And Retained Earnings

KAKEN PHARMACEUTIAL CO., LTD. - Filing #7600343

Concept 2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
15,710,000,000 JPY
17,429,000,000 JPY
17,064,000,000 JPY
JPY
17,064,000,000 JPY
1,353,000,000 JPY
1,418,000,000 JPY
16,370,000,000 JPY
JPY
17,788,000,000 JPY
17,744,000,000 JPY
17,788,000,000 JPY
Non-operating income
Non-operating income
502,000,000 JPY
543,000,000 JPY
484,000,000 JPY
484,000,000 JPY
Non-operating expenses
Non-operating expenses
66,000,000 JPY
66,000,000 JPY
50,000,000 JPY
50,000,000 JPY
Ordinary profit (loss)
17,866,000,000 JPY
17,542,000,000 JPY
18,222,000,000 JPY
18,178,000,000 JPY
Extraordinary income
Extraordinary income
197,000,000 JPY
197,000,000 JPY
495,000,000 JPY
495,000,000 JPY
Extraordinary losses
Extraordinary losses
3,854,000,000 JPY
3,854,000,000 JPY
59,000,000 JPY
59,000,000 JPY
Profit (loss) before income taxes
14,209,000,000 JPY
13,885,000,000 JPY
18,657,000,000 JPY
18,613,000,000 JPY
Income taxes - current
4,487,000,000 JPY
4,513,000,000 JPY
4,979,000,000 JPY
4,967,000,000 JPY
Income taxes - deferred
-175,000,000 JPY
-177,000,000 JPY
272,000,000 JPY
269,000,000 JPY
Profit (loss)
9,897,000,000 JPY
9,897,000,000 JPY
9,897,000,000 JPY
9,897,000,000 JPY
9,549,000,000 JPY
13,376,000,000 JPY
13,376,000,000 JPY
13,405,000,000 JPY
13,376,000,000 JPY
13,376,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.